Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives. Apple and Masimo have ...

It's been more than a year since Apple Watch Ultra 2 launched, and we've had the wearable that's only gotten better on our ...

Irvine-based Masimo’s W1 Medical Watch gives “medical-grade accuracy a cut above most fitness trackers,” the magazine said.

Following after the Apple Watch Series 10, Apple is expected to bring out the Apple Watch Series 11. If previous scheduling is an indicator, the Apple Watch Series 11 is expected to launch in late ...

Unrecognized Contract Revenues: $1.65 billion as of the end of Q3. Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for the third quarter, representing a 12% growth compared ...

On Wednesday, Masimo Corp. (NASDAQ:{{16565|MAMASI) shares received an upgrade from Raymond (NS:RYMD) James, moving from a "Market Perform" to an "Outperform" rating. The firm has set a price ...

Masimo Corp. ( (MASI)) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo Corporation, a global technology company specializing in ...

On Wednesday, Piper Sandler maintained an Overweight rating on shares of Masimo Corp. (NASDAQ:{{16565|MAMASI) and increased the price target to $180 from $165. The adjustment follows Masimo's ...